Login
Toggle navigation
Videos
Categories
Trending
Tim Fitzpatrick, CEO and Co-Founder of IKONA Health, discusses their innovative kidney education platform designed for improved learning outcomes.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
David Cho is CEO of IKONA Partners
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Switch to Better Credit Card Processing Today
00:00:00
Inflammation & Antibodies with Ampio Pharmaceutical - Michael A. Martino, Chief Executive Officer, Ampio Pharmaceuticals Inc
00:10:00
Evolving Story: Investing in Africa's Renewable Energy Future | Akinwole Omoboriowo ll, CEO, Geregu Power PLC.
00:10:00
American West Metals' Copper-Zinc Projects in Utah and Canada: Insights from Managing Director Dave O'Neill | Dave O'Neill, Managing Director , American West Metals Ltd.
00:10:00
How America Can Regain Economic Competitiveness | Richard Dauch, CEO, American Axle & Manufacturing.
00:10:00
Revolutionizing Mining Operations: A Deep Dive into Mine Vision Systems | Mike Smocer, CEO of Mine Vision Systems
00:10:00
Insights from Kotak Mutual Fund on Post-Election Outlook and Global Dynamics | Nilesh Shah, CEO , Kotak Mutual Fund .
00:10:00
The Exchange: Sandra Testani on American Century's ESG ETF Strategies
00:10:00
Meta's Threads Launch: Strategic Insights and Market Dynamics |Roger McNamee, Co-Founder, Elevation Partners.
00:10:00
ONE Gas CEO provides insight on the company's evolution and the future of natural gas in an interview with Tulsa World.
00:10:00
Avino Silver CEO David Wolf Discusses Market Conditions and Company Updates
00:10:00
Sarah-Marie Martin on Private Capital Growth and the Evolving PE Landscape